AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vildacos M 500mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

In Med Therapeutics

Salt Composition

Metformin (500mg) + Vildagliptin (500mg)

Overview Vildacos M 500mg/500mg Tablet SR

Diabetac Duo 500mg/500mg Extended-Release Tablets combine two agents to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, and may lessen the risk of cardiovascular events. Diabetac Duo may be used alone or in conjunction with other antidiabetic therapies. Optimal efficacy is achieved with a balanced diet and regular physical activity. Dosage is individualized based on your health status, glycemic control, and other medications. Consuming it with meals minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under medical supervision. Effective blood sugar management minimizes future complications. Adherence to your physician's prescribed diet and exercise regimen is crucial for successful diabetes management, as lifestyle significantly impacts glycemic control. Commonly reported side effects include diarrhea, nausea, vomiting, dyspepsia, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential adverse effect, especially when co-administered with insulin or sulfonylureas; prompt recognition and treatment are essential. This medication isn't suitable for all patients. Prior to commencement, disclose any history of renal, hepatic, or cardiac disease, pancreatic dysfunction, or significant alcohol consumption to your physician. Pregnant or lactating women require medical consultation before initiating treatment. Inform your doctor of all other medications you are taking to ensure safety and compatibility. Alcohol consumption should be minimized due to its potential for hypoglycemia. Your physician will monitor renal function and blood glucose levels throughout treatment.

Primary Ingredients of Vildacos M 500mg/500mg Tablet SR

No information provided. Please provide the text you wish me to rephrase.

Uses of Vildacos M 500mg/500mg Tablet SR

Managing Type 2 diabetes

Major Benefits of Vildacos M 500mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Vildacos M 500mg/500mg Sustained-Release Tablet should be taken with a meal.

Common Side effects of Vildacos M 500mg/500mg Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildacos M 500mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Vildacos M 500mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

How Vildacos M 500mg/500mg Tablet SR works:

Each Vildacos M 500mg/500mg extended-release tablet contains a dual antidiabetic medication formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vildacos M 500mg/500mg SR tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Vildacos M 500mg/500mg tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Vildacos M 500mg/500mg tablets are likely unsafe for breastfeeding mothers. Available evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired if your blood glucose levels are abnormally low or elevated. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vildacos M 500mg/500mg sustained-release tablets cautiously. Dosage modification may be necessary; physician consultation is advised.

LiverLiverUNSAFE

Extended-release Vildacos M 500mg/500mg tablets are likely contraindicated for individuals with hepatic impairment and should be omitted. Physician consultation is recommended.

What if you forget to take Vildacos M 500mg/500mg Tablet SR :

Should you forget to take a Vildacos M 500mg/500mg Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Vildacos M 500mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vildacos M 500mg/500mg Tablet SR

Vildacos M 500mg/500mg SR tablets rarely cause hypoglycemia on their own. However, low blood sugar can result from inadequate caloric intake while using this medication. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These are more likely if you skip meals, consume alcohol, overexert yourself, or use other antidiabetic medications concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vildacos M 500mg/500mg Tablet SR. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's approval.
Vildacos M 500mg/500mg Tablet SR is contraindicated in patients with allergies to its components or excipients. It should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vildacos M 500mg/500mg SR tablets combine metformin (a biguanide) and vildagliptin to manage diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated in patients under 18.
Vildacos M 500mg/500mg Tablet SR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency characterized by high blood lactic acid levels. This rare side effect necessitates avoiding use in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Vildacos M 500mg/500mg Tablet SR and seek immediate medical attention.
Prolonged use of Vildacos M 500mg/500mg SR tablets can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left unaddressed, could result in anemia and neurological complications.
Vildacos M 500mg/500mg SR tablets are safe when used as directed by your doctor. However, even with proper usage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (especially if you also take insulin or sulphonylurea) may occur. Report any persistent side effects to your physician.
Vildacos M 500mg/500mg Ta...
190
MRP 220
13% off